Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Lactobacillus or Pediococcus or Leuconostoc

Subclass of:

424 - Drug, bio-affecting and body treating compositions

424930100 - WHOLE LIVE MICRO-ORGANISM, CELL, OR VIRUS CONTAINING

424930400 - Bacteria or actinomycetales

Patent class list (only not empty are listed)

Deeper subclasses:

Entries
DocumentTitleDate
20090317370Methods And Means For Protecting The Skin Against Pathogenic Microorganisms - Described are microorganisms which are, in a first aspect, able to to stimulate the growth of microorganisms of the resident skin microbial flora and which do not stimulate the growth of microorganisms of the transient pathogenic micro flora. In a second aspect microorganisms are described which are able to inhibit the growth of microorganisms of the transient pathogenic skin micro flora and which do not inhibit the growth of microorganisms of the resident skin micro flora. Also described are compositions comprising such microorganisms as well as the use of such microorganisms in cosmetic, prophylactic or therapeutic applications.12-24-2009
20110177044Nutritional Formulas Containing Synbiotics - The present disclosure relates to a synbiotic composition comprising the probiotic 07-21-2011
20090214497Novel Acid Tolerant Lactobacillus Sakei Probio-65 with the Ability of Growth Suppression of Pathogenic Microorganisms and the Anti-Allergic Effect - Disclosed are a novel tactic acid bacterium, 08-27-2009
20100021444BLOOD-ADIPONECTIN-CONCENTRATION INCREASE-ACCELERATOR AND/OR DECREASE-INHIBITOR THEREOF AND VISCERAL FAT ACCUMULATION INHIBITOR - Disclosed is an agent for accelerating the increase in and/or preventing the decrease in the blood adiponectin level, or a food, beverage or animal feed for accelerating the increase in and/or preventing the decrease in the blood adiponectin level, which comprises a culture or cell of a lactic acid bacterium belonging to the genus 01-28-2010
20080206212METHOD FOR THE UTILIZATION OF AND PRODUCT CONTAINING INACTIVATED PROBIOTIC - A novel method and product utilizing or containing one or more inactivated probiotics.08-28-2008
20100086527SYNBIOTIC TO IMPROVE GUT MICROBIOTA - The use of a probiotic strain of 04-08-2010
20110195057Growth Inhibition and Elimination of Methicillin-Resistant Staphylococcus Aureus by Lactic Acid Bacteria - The present invention relates to methicillin-resistant 08-11-2011
20100158882IMMUNOMODULATING PROBIOTIC LACTIC ACID BACTERIA - The present invention relates to immuno modulating probiotic lactic acid bacteria, to methods wherein the bacteria are used to reduce allergy, and to food products wherein the bacteria may be in incorporated to reduce allergy upon consumption of the product. Preferred probiotic lactic acid bacteria stimulate the Th1 and/or Th3 responses and/or represses Th2 responses as may be determined by the cytokine profiles that are induced in human peripheral blood mononuclear cells upon coincubation with the lactic acid bacteria.06-24-2010
20100074878Probiotic bacterium: lactobacillus fermentum - Variant of the bacterium 03-25-2010
20120183516Lactic acid bacteria and bifidobacteria for treating endotoxemia - The invention relates to use of a bacterium selected from a lactic acid bacterium, a 07-19-2012
20090274672Lactobacillus Isolates Having Anti-Inflammatory Activities and Uses of the Same - Disclosed herein are two 11-05-2009
20090136468PERI-OPERATIVE COMPOSITION COMPRISING LACTOBACILLUS RHAMNOSUS - The present invention relates to the field of human health and uses of 05-28-2009
20100129334Use of Lactobacillus casei for Increasing the Protection Provided by the Influenza Vaccine - The invention relates to the use of 05-27-2010
20100104545Nutritional Composition To Promote Healthy Development And Growth - A nutritional composition having a lipid or fat; a protein source; a source of long chain polyunsaturated fatty acids which comprises docosahexanoic acid; and up to about 2.5% by weight of a source of supplemental calcium which, when dissociated, provides a cation having prebiotic functionality.04-29-2010
20100330055DISEASE RESISTANCE ENHANCER FOR PLANTS AND METHOD OF CONTROLLING PLANT DISEASE BY USING THE SAME - Infection of pathogens is controlled by inducing disease resistance with a method of treating a plant with a composition of an acidic heat-treated solution of microorganisms.12-30-2010
20130028877LACTOBACILLUS JOHNSONII La1 NCC533 (CNCM I-1225) AND IMMUNE DISORDERS - The present invention generally relates to the field of preventing and/or treating inflammatory and infectious disorders, in particular by boosting the endogenous antimicrobial defences. One embodiment of the present invention is the use of non-replicating 01-31-2013
20130089531METHOD FOR INHIBITION OF BLOOD PHOSPHORUS LEVEL ELEVATION - The present invention provides a method for inhibiting blood phosphorus level elevation, including administering to a patient in need thereof a composition comprising a lactic acid bacterium as an active ingredient. The method may further include encapsulating the composition comprising a lactic acid bacterium in a capsule. The inhibitor for blood phosphorus level elevation of the present invention is highly safe, is readily administrable, and can sufficiently inhibit a blood phosphorus level elevation.04-11-2013
20130052171IMMUNOMODULATORY ISOLATED LACTOBACILLUS STRAINAND APPLICATION THEREOF - An immunomodulatory isolated 02-28-2013
20130052172METHODS FOR DIAGNOSING AND TREATING CARDIAC DEFECTS - The present disclosure defines a method for identifying and/or treating risk and/or occurrence of cardiac defect. As is shown herein, microbiomes are reproducibly and detectably associated with cardiac defect risk factors and changes to the microbiome can directly alter cardiac defect risk. The present disclosure demonstrates that microbial signatures can be used to characterize components of microbiomes that associate with altered risk or occurrence of cardiac defects and to identify treatments to reduce risk or severity of cardiac defects.02-28-2013
20090311227Composition - The present invention relates to a composition comprising: i) at least one strain of a 12-17-2009
20090304656CONTROLLED ACTIVATION OF THE REUTERIN-PRODUCTION MACHINERY OF LACTOBACILLUS - Methods for the controlled activation of the reuterin-production machinery of 12-10-2009
20090041736SYNBIOTIC MIXTURE - This invention relates to a preparation comprising a probiotic bacterial strain and a prebiotic mixture comprising 5-70 wt % of at least one N-acetylated oligosaccharide selected from the group comprising Ga1NAcα1,3Ga1β1,4G1c and Ga1β1,6Ga1NAcα1,3Ga1β1,4G1c, 20-95 wt % of at least one neutral oligosaccharide selected from the group comprising Ga1β1,6Ga1, Ga1β1,6Ga1β1,4G1c Ga1β1,6Ga1β1,6G1c, Ga1β1,3Ga1β1,3G1c, Ga1β1,3Ga1β1,4G1c, Ga1β 1,6Ga1β 1,6Ga1β 1,4G1c, Ga1β 1,6Ga1β 1,3Ga1β 1,4GIc Ga1β 1,3Ga1β 1,6Ga1β 1,4GIc and Ga1β1,3Ga1β1,3Ga1β1,4G1c and 2-50 wt % of at least one sialylated oligosaccharide selected from the group comprising NeuAcα2,3Ga1β1,4G1c and NeuAcα2,6Ga1β1,4G1c. The invention extends to food products comprising said preparation and to the use of the preparation in the prevention and treatment of infections.02-12-2009
20130071368PREPARATION, USE OF PREPARATION FOR TREATMENT, AND METHOD OF TREATMENT OF INTESTINAL INFECTION - A preparation for use in the treatment of 03-21-2013
20090092590METHOD FOR IMPROVING STOOL CHARACTERISTICS IN INFANTS - In accordance with the present invention, a novel method for improving the stool characteristics, reducing the incidence of diarrhea, and firming the stool of a formula-fed infant of a formula-fed infant has been discovered. The method comprises administering to the infant at least one prebiotic and hydrolyzed pectin.04-09-2009
20110014167USE OF PROBIOTICS AND FIBERS FOR DIARRHOEA - The present invention relates to nutritional compositions comprising 01-20-2011
20110064707PROBIOTICS TO IMPROVE GUT MICROBIOTA - The use of probiotic bacteria in the manufacture of a medicament or therapeutic nutritional composition for promoting the development of an early bifidogenic intestinal microbiota in infants without siblings.03-17-2011
20090269321Immune Function Modulating Agents - A probiotic 10-29-2009
20120225042COMPETITIVE EXCLUSION COMPOSITION AND METHODS - The present invention relates to compositions, including live organisms, nucleic acid and amino acid sequences, constructs and cells comprising these, which are used to competitively exclude pathogenic organisms from the alimentary canals of vertebrates to achieve prophylaxis or therapeutic effects.09-06-2012
20120114622LACTOBACILLUS RHAMNOSUS AND WEIGHT CONTROL - The present invention generally relates to the field of obesity. In particular the present invention relates to the use of probiotics to treat obesity. One embedment of the present invention relates to the use of 05-10-2012
20090010903Ferulate Esterase Producing Strains and Methods of Using Same - Ferulate esterase producing bacterial strains or functional mutants thereof and methods of using ferulate esterase producing bacterial strains as forage additives are disclosed.01-08-2009
20090010904Immunostimulating Agent and Method for Production Thereof - The object is to provide: a safe immunomodulating agent which can be used as a pharmaceutical or a food material; a method for production of the immunomodulating agent; and a novel application of a coffee extract residue. Disclosed is an immunomodulating agent comprising a coffee extract as an active ingredient. Preferably, the coffee extract is an extract containing arabinogalactan. The immunomodulating effect of the immunomodulating agent relies on the promotion of the proliferation of an immunocompetent cell such as a macrophage. The immunocompetent cell is preferably any one selected from a macrophage like strain RAW264 or J774.1, a murine splenocyte, a murine peritoneal macrophage and a murine dendrocyte. A composition containing the immunomodulating agent can be used as a composition such as a pharmaceutical composition, a food composition and a cosmetic composition.01-08-2009
20110020304SYNBIOTIC MIXTURE - This invention relates to a preparation comprising N-acetyl-lactosamine and/or an oligosaccharide containing N-acetyl-lactosamine and a probiotic 01-27-2011
20080305090COMPOSITION FOR PROMOTING THE PROLIFERATION OF LACTOBACILLUS CASEI SUBSP. CASEI - A composition for promoting bacterial proliferation and selectively proliferating 12-11-2008
20090130072Use of Lactobacillus Kefiranofaciens as a Probiotic and a Synbiotic - In accordance with the present invention, there is provided a probiotic composition comprising an effective amount of 05-21-2009
20110002902INHIBITOR FOR BLOOD PHOSPHORUS LEVEL ELEVATION - The present invention provides an inhibitor for blood phosphorus level elevation comprising a lactic acid bacterium as an active ingredient. The inhibitor for blood phosphorus level elevation of the present invention is highly safe, is readily administerable, and can sufficiently inhibit a blood phosphorus level elevation.01-06-2011
20100080783Microbial feed additive - A microbial feed additive comprising lactic acid bacteria, silicate such as bentonite, and a yeast culture. The animal feed additive of this invention results in more piglets born alive, reduced mortality in nursery pigs, improved growth performance in pregrower, growing and finishing pigs, improved utilization of dietary protein in pregrower and finishing pigs, and improved growth performance in stressed pigs.04-01-2010
20110280848COMPOSITION COMPRISING CHICORIC ACID AND/OR DERIVATIVES THEREOF - The present invention relates generally to the field of food and drinks. In particular, for example, a composition is provided that allows to provide tartaric and/or caffeic acid to a subject. One embodiment of the present invention is a composition comprising an ingredient containing chicoric acid and/or derivatives thereof, and a lactic acid bacterium capable of hydrolysing chicoric acid and/or derivatives thereof to generate tartaric and/or caffeic acid.11-17-2011
20090028839Compositions and methods for the prophylaxis and treatment of vaginal infections - Applicants have discovered that a particular bacteriocin from the vaginal strain of 01-29-2009
20090208469Use of Lactobacillus for Treatment of Autoimmune Diseases - The present technology relates to the use of at least one strain of probiotic bacteria selected from 08-20-2009
20100061967Use - Use of at least one strain of a microorganism and/or a metabolite thereof in the manufacture of a support for administration to a subject for modulating satiety signalling, wherein the support is a pharmaceutically acceptable support or a food product. Suitably, the at least one strain of a microorganism and/or a metabolite thereof may be administered to the subject for the treatment and/or prevention of excess weight and/or a disease caused by excess weight. Likewise, the at least one strain of a microorganism and/or a metabolite thereof is administered to the subject for the treatment and/or prevention of obesity and/or a caused by obesity. Preferably, the microorganism is a probiotic microorganism. Suitably the microorganism may be a lactic acid bacterium. Li one embodiment the microorganism is a strain of 03-11-2010
20110300118AGENTS FOR PROMOTING IGA PRODUCTION - The present invention provides 12-08-2011
20090280099NASOPHARYNGEAL INOCULATE OF PROBIOTICS AND PREBIOTICS FOR TREATMENT OF RESPIRATORY INFECTIONS - The present invention is directed to compositions comprising one or more species of probiotic bacteria, optionally in combination with one or more prebiotics, to methods of preventing and treating respiratory infections in animals by employing such compositions, and to methods of preparing the same.11-12-2009
20120189599MEDICATION FOR ORAL ADMINISTRATION, COMPRISING AT LEAST ONE ESTROGEN AND/OR AT LEAST ONE GESTAGEN AND AT LEAST ONE PROBIOTIC BACTERIAL STRAIN - The present invention relates to a medicament for oral administration containing at least one estrogen and/or one gestagen and at least one probiotic bacterial strain, such as for example 07-26-2012
20090130073Microorganisms Inhibiting the Formation of Foot Malodor - Described are microorganisms which are able to inhibit the formation of foot malodor by skin microorganisms. Also described are compositions comprising such microorganisms as well as the use of such microorganisms in cosmetic, prophylactic or therapeutic applications.05-21-2009
20100111915PROBIOTICS FOR REDUCTION OF RISK OF OBESITY - The use of probiotic bacteria capable of promoting the development of an early bifidogenic intestinal microbiota in the manufacture of a medicament or therapeutic nutritional composition for reducing the risk of development of overweight or obesity of an infant later in life.05-06-2010
20090081174Synergistic fungicidal compositions - Fungicidal compositions are described, consisting of mixtures comprising a copper (II) salt of phosphorous acid and at least another metallic salt of phosphorous acid or consisting of mixtures comprising a copper (II) salt of phosphorous acid, alone or mixed with at least another metallic salt of phosphorous acid, and one or more fungicidal compounds, and their use for the control of phyto-pathogen fungi.03-26-2009
20100086528NOVEL BACTERIA ISOLATED FROM FRESH HONEY OR THE HONEY PRODUCING TRACT OF HONEY BEES - The invention relates to new isolated 04-08-2010
20120034199MONOGASTRIC ANIMAL FEED - The present invention relates an improved feed additive or food supplement formulation obtained from more than one strain of Lactic acid bacteria. The feed additive or supplements is used to feed monogastric animals such as avian, fowl. Moreover, the feed provides better growth and feed utilization for monogastric animals. Further, the animal feed can be used for controlling food intake in the animals.02-09-2012
20120107291Bifidobacteria for treating diabetes and related conditions - This invention relates to new uses of Bifidobacteria (particularly, although not exclusively, probiotic Bifidobacteria), and to food products, feed products, dietary supplements and pharmaceutical formulations containing them. The bacteria are suitable for the treatment of diabetes (particularly Type 2 diabetes), obesity and related conditions, metabolic syndrome, insulin resistance, and impaired glucose metabolism and consequences thereof, lowering tissue inflammation, treating hepatitis, myositis and cardiovascular conditions.05-03-2012
20120107290NON-REPLICATING MICRO-ORGANISMS AND THEIR IMMUNE BOOSTING EFFECT - The present invention generally relates to the field of probiotic bacteria. In particular, the present invention conceras non-replicating probiotics, such as the genus Lactobacillus, Bifidobacterium or combinations thereof, for example 05-03-2012
20120107289Lactic Bacteria and Their Use in the Prevention of Diarrhea - The present invention concerns a lactic composition useful for the prevention or treatment of diarrhea such as antibiotic associated diarrhea or “tourista.” The composition according to the invention contains at least a bacterial strain selected from the group consisting of 05-03-2012
20120107288COMPOSITIONS AND METHODS FOR INHIBITING PATHOGENIC GROWTH - The invention includes methods and compositions for treating an animal to inhibit the incidence and growth of 05-03-2012
20110200569INCREASING THE SHELF LIFE OF BAKERY AND PATISSERIE PRODUCTS BY USING THE ANTIFUNGAL LACTOBACILLUS AMYLOVORUS DSM 19280 - The current inventions relates to a strain of 08-18-2011
20090291069NOVEL STRAIN OF THE GENUS LACTOBACILLUS AND TOPICAL PHARMACEUTICAL FORMULATIONS CONTAINING IT - This invention relates to a novel strain of 11-26-2009
20080206213METHOD FOR REDUCING OR PREVENTING SYSTEMIC INFLAMMATION - The present invention is directed to a novel method for treating or preventing systemic inflammation in a subject. The method administering to the subject a therapeutically effective amount of inactivated LGG.08-28-2008
20090104169PET FOOD COMPOSITION FOR SKIN PHOTOPROTECTION - An ingestable composition for the photoprotection of the skin of pets which comprises a photoprotecting effective amount of i) at least one probiotic lactic acid bacterium or a culture supernatant thereof, and ii) at least one yeast and/or a carotenoid or derivative, included into an ingestable carrier.04-23-2009
20100278796Method for Improving the Digestibility and the Assimilability of Cereals and/or Fibres in a Monogastric Herbivorous Animal - The invention relates to a method for improving the digestibility and assimilability of fibres and/or cereals in a monogastric herbivorous animal comprising the step of administering to said monogastric herbivorous animal an effective amount of at least one strain of bacterium selected fromselected from the group consisting of strains of bacteria of the genera 11-04-2010
20100278794AGENT FOR PROMOTING THE SECRETION OF AND/OR SUPPRESSING DECREASE OF ADIPONECTIN - An agent for promoting the secretion of adiponectin and/or suppressing decrease of adiponectin, a food or beverage for promoting the secretion of adiponectin and/or suppressing decrease of adiponectin, and a feed, each of which comprises a culture supernatant of 11-04-2010
20100129337Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter - Strains of 05-27-2010
20110200570Composition and Method for Treating Infections and Promoting Intestinal Health - Compositions and methods for the treatment of intestinal infections. Compositions that include a liquid crystal mixture of an antimicrobial glycerol fatty acid ester and a polyhydric alcohol inhibit the growth of numerous deleterious intestinal pathogenic bacteria, including 08-18-2011
20100291051AGENT FOR PREVENTION OF ALCOHOLIC HEPATOPATHY - The present invention provides an agent for inhibition of alcoholic hepatopathy comprising cells of a strain belonging to Lactobacillus brevis, or treated product thereof as an active ingredient. The agent for inhibition of alcoholic hepatopathy of the present invention is safe for living body and can be used as a component in foods and beverages.11-18-2010
20090169531Use of symbiotic for the treatment of atopic dermatitis - The invention relates to the use of a product comprising a living 07-02-2009
20090169530Plant disease controlling agent and controlling method - A plant disease controlling agent containing a lactic acid bacterium which is capable of controlling plant disease and a plant disease controlling method which comprises treating a plant and/or soil with the above-mentioned lactic acid bacterium. By using the lactic acid bacterium seemingly advantageous to human health, an agricultural crop can be safely and stably produced. As the lactic acid bacterium as mentioned above, use may be favorably made of a microorganism belonging to the genus 07-02-2009
20100129333ANTI-FATTY LIVER AGENT - Disclosed is an anti-fatty liver agent comprising a cell and/or a culture obtained by culturing a lactic acid bacterium belonging to 05-27-2010
20100129335REDUCTION OF RISK DIARRHOEA - The use of a probiotic 05-27-2010
20120294841PROBIOTIC MICROORGANISMS AS ACTIVE AGENTS AGAINST CHANGES IN THE SKIN'S MICRORELIEF - The invention relates to the use of at least one probiotic microorganism as an active agent for preventing and/or treating impairments of the skin's microrelief.11-22-2012
20080286254Composition comprising licorice polyphenol - A composition containing a licorice polyphenol and other active ingredient (antioxidant ingredient, polyphenol other than licorice polyphenol or a component relating to lipid absorption or metabolism) is highly safe, can be produced easily, and can be utilized for foods and drinks such as health food, food with health claims (specified health food, food with nutrient function claims) and the like, pharmaceutical products, quasi-drugs, cosmetics and the like. In addition, since the composition has a body fat accumulation suppressing effect, a body fat decomposition promoting effect or energy production promoting effect, it is useful for the treatment of obesity, metabolic syndrome and the like.11-20-2008
20080286253Composition Comprising Polymeric Material And Uses Thereof - Compositions for the selective delivery of an agent comprising an uncrosslinked starch modified by an acidic group and an agent are described. The compositions are substantially resistant to degradation and thus result in no or substantially no release of the agent in a first environment, and are capable of degradation in a second environment thereby allowing release of the agent. The pKa of the acidic group of the uncrosslinked starch used is higher than the pH of the first environment and lower than or equal to the pH of the subsequent environment. Also described herein are methods of preparing the compositions, methods of using the compositions and the uncrosslinked starch modified by an acidic group, and corresponding commercial packages.11-20-2008
20090324563MOISTURIZER - The present invention provides a moisturizer comprising heat-killed cells of 12-31-2009
20080292604Canine probiotic lactobacilli - According to the invention there is provided a strain of lactic acid bacteria of the genus 11-27-2008
20110206649NUTRITIONAL COMPOSITION COMPRISING PROBIOTICS AND IMPROVING SLEEP PATTERNS - This invention relates to the use of a probiotic bacterial strain in the manufacture of a medicament or therapeutic nutritional composition for improving the maturation of sleep patterns in infants, young children or young animals and/or for reducing sleep disturbances and/or improving sleep patterns in humans or animals at any age.08-25-2011
20110014168LACTIC ACID BACTERIA HAVING ACTION OF LOWERING BLOOD URIC ACID LEVEL - Various types of lactic acid bacteria were cultured in the presence of a purine, the amount of the purine consumed and the amount of purine degradation products produced were measured, and several lactic acid bacteria showing remarkable purine-decomposing ability were selected. Lactic acid bacteria that were assessed to have high purine-decomposing ability according to the above-mentioned selection were orally administered to rats reared on purine-containing feed, the general status and serum uric acid level of the rats were measured, and the effect of lactic acid bacteria administration on serum uric acid levels was examined. As a result, lactic acid bacteria that significantly suppress the increase of serum uric acid levels, 01-20-2011
20110206650Probiotic Formulations - The present invention relates to probiotic compositions and kits thereof, comprising live bacteria belonging to the natural flora of the human body cavity such as intestine and vaginal tract, in particular, strains of 08-25-2011
20090028840Compositions For Preventing Or Treating Arthritis Comprising Lactic Acid Bacteria and Collangen As Active Ingredients - The present invention relates to a composition for preventing or treating arthritis, which comprises a lactic acid bacterium and collagen as major active ingredients. The present composition shows excellent prevention or treatment efficacies on arthritis of animal models. In addition, since the active ingredients used in the composition of this invention have been recognized to be safe to human, the present composition has considerable safety with enhanced immunomodulatory effect in patients with arthritis.01-29-2009
20130216510Probiotic Strains for Use in Improving Transepithelial Resistance - The invention relates to the use of lactic acid bacteria, for use in improving transepithelial resistance and more particularly in treating and/or preventing constipation and/or irritable bowel disease.08-22-2013
20130121977LACTOBACILLUS PLANTARUM SPECIES POSSESSING BROAD SPECTRUM ANTI-FUNGAL ACTIVITY AND EXHIBITING HIGH HEAT TOLERANCE AND OSMOTOLERANCE - Isolated strains of 05-16-2013
20090074735TOPICAL PRODUCT CONTAINING SACRIFICIAL MATERIAL FOR NEUTRALIZING FREE RADICALS - A topical product to protect the skin from free radicals is disclosed in one embodiment of the invention as including a carrier medium for topical application to the skin. A sacrificial material that is compatible with the skin is interspersed with the carrier medium. This sacrificial material may be selected to react with free radicals within the skin. The sacrificial material may be further selected to react with water to produce hydrogen (a powerful antioxidant) and a reaction product that is also compatible with the skin. In this way, both the sacrificial material and the hydrogen will react with free radicals to provide protection against free radicals.03-19-2009
20090004165Feline probiotic Lactobacilli - According to the invention there is provided a strain of lactic acid bacteria of the genus 01-01-2009
20110229447NUTRITIONAL SUPPORT TO PREVENT OR MODERATE BONE MARROW PARALYSIS OR NEUTROPENIA DURING ANTI-CANCER TREATMENT - The present invention relates to methods and immunonutritional compositions for preventing the impairment of the immune function during anti-cancer therapy, thereby attaining a better efficacy of the treatment. More particularly, the present invention relates to methods and immunonutritional compositions that can transiently preventing or moderating, bone marrow paralysis or neutropenia of a subject undergoing anti-cancer therapy-induced apoptosis or necrosis or other cell damage such that the innate and adaptive immune functions and normal physiology of the bone marrow are preserved, at least in part, which, in turn, lead to (i) a better tolerance and increased efficacy to anti-cancer therapy; (ii) transient augmentation or enhancement of immunocompetence of the immune cell; and (iii) optimization of the effects of and increase of immunocompetence of the immune cell weakened by anti-cancer therapy.09-22-2011
20110229446Method and composition to relieve sexual discomfort and improve vaginal health - A method to reduce sexual discomfort for a woman during sexual intercourse vaginally introduces a lubricant composition comprising carrageenan comprising 0 to 92% by weight iota carrageenan, 10% to 100% by weight lambda carrageenan, and, 0 to 18% by weight kappa carrageenan; water such that the ratio of carrageenan to water is in the range of 1:10 to 1:50; at least one prebiotic; and, a natural humectant with a peak tackiness force of less than 50 g and a work of adhesion of less than 0.500 GS.09-22-2011
20100178281SUPPLEMENTION OF MATERNAL DIET - The use of probiotic bacteria in the manufacture of a composition for administration to a woman in at least the third trimester of pregnancy for prevention of gestational diabetes, normalising plasma glucose concentration and/or increasing insulin sensitivity.07-15-2010
20120195868NUTRITIONAL COMPOSITIONS COMPRISING FIBER AND PROBIOTICS - Nutritional compositions including fiber blends having a stable amount of probiotics and methods of making the nutritional compositions are provided. In a general embodiment, the present disclosure provides a nutritional composition including a fiber blend having agglomerated fiber particulates and a probiotic. The fiber blend can have a water activity of less than about 0.15. The nutritional composition can be in an administerable form such as pharmaceutical formulations, nutritional formulations, dietary supplements, functional foods and beverage products.08-02-2012
20090104168Use of Specific Lactic Bacteria for the Preparation of Immunomodulating Compositions - The invention concerns the use of two lactobacteria for the preparation of immunomodulating compositions, in particular for the treatment and/or prevention of allergies and immunodeficiencies, and specifically use of the following two strains 04-23-2009
20090104167Prophylactic/Ameliorating Agent for Menopausal Disorder and Functional Beverage/Food - Disclosed is a method for producing an estrogen-like active intermediate (e.g., secoisolariciresinol) by culturing a lignan (e.g., a lignan derived from 04-23-2009
20090047264ANTIALLERGIC AGENT, UTILIZATION THEREOF FOR REDUCING ALLERGY AND METHOD OF REDUCING ALLERGY - The present invention provides an antiallergic agent containing, as an active ingredient, lactic acid bacteria selected from the group consisting of lactic acid bacteria of the species 02-19-2009
20110059058Strain of Lactobacillus Rhamnosus - The invention relates to a novel strain of 03-10-2011
20110110905Infant Colic Supplement - Given the benefits of probiotic and digestive enzyme supplementation separately, a dietary supplement that includes both probiotic and digestive enzymes is advantageous for the treatment of infantile colic. The present invention is a novel supplement containing 05-12-2011
20100254956PROBIOTIC BACTERIA AND REGULATION OF FAT STORAGE - The present invention provides methods for manufacturing heat treated products involving the use of probiotic bacteria, e.g. lactic acid bacteria and/or Bifidobacteria, cultures of such bacteria, supernatant from such cultures, and/or concentrates of such supernatant and/or fractions of such supernatant. The invention further provides heat treated products of such processes and their use for regulation of cellular uptake of fat and/or triglycerides and/or body weight management or weight reduction and/or redistribution of fat and/or reduction in visceral and/or abdominal fat deposition in a subject.10-07-2010
20100203026PROBIOTICS FOR INDUCING SATIETY AND/OR SATIATION - The invention relates to the field of nutrition and medicine. Provided are compositions, bacterial strains and methods for inducing or enhancing satiety and satiation and for treating or preventing obesity, overweight and overweight related diseases.08-12-2010
20100196341Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof08-05-2010
20120034200Formulations Including Digestive Enzymes, Polysorbate-Based Surfactants and Probiotics - Disclosed are formulations for enhancing the in vivo colonization of probiotic microorganisms that include digestive enzymes and probiotic microorganisms, and polysorbate surfactants. The enzymes include lactogenic enzyme formulations that promote growth of 02-09-2012
20090257993Lactic Acid Producing Bacteria and Lung Function - The present invention provides novel use for live (probiotic) lactic acid producing bacteria, dead or non-viable bacteria thereof, as well as food supplements, nutritive compositions and/or pharmaceutical compositions comprising these, for the treatment or prophylaxis of lung dysfunction in a subject. A suitable lactic acid producing bacterium has a significant beneficial effect on airway narrowing determined by measuring the enhanced pause value (Penti) of a test animal.10-15-2009
20090142314MATERNAL SUPPLEMENT - The use of docosahexaenoic acid in the manufacture of a composition for administration to a pregnant woman for reducing the risk of development of overweight or obesity of the baby in infancy and/or early childhood.06-04-2009
20100278795LACTIC ACID BACTERIUM-CONTAINING PREPARATION - An object of the present invention is to provide a useful composition that contains a highly safe lactic acid bacterium or a component derived from this lactic acid bacterium. The present invention relates to a composition comprising at least one lactic acid bacterium selected from the group consisting of 11-04-2010
20110117068PROBIOTIC MICROORGANISMS FOR THE REDUCTION OF MANURE ODOR - Described are microorganism which are able to reduce the generation of feces odor by decreasing the amount of at least one of the compounds methyl mercaptan, a sulphide compound, cadavarine, putrescine, indole or skatole, and wherein said decrease in the amount of said compounds is independent of the growth of the microorganism. Also described are compositions, comprising such microorganisms, e.g. food, feed or pharmaceutical compositions and the use of such microorganisms for suppressing feces odor or the preparation of foodstuff or feedstuff, as well as corresponding methods for the production of food or feed composition and additives for food, feed or drinks.05-19-2011
20100303777DELIVERY OF BINDING MOLECULES TO INDUCE IMMUNOMODULATION - Delivery of binding molecules, such as antibodies, antibody fragments, single antibody variable domains, soluble receptors, ligands and dominant negative variants, to induce an immunomodulation in a patient is disclosed. More specifically, a medicament which includes micro-organisms which produce the binding molecules is described for the treatment of immune mediated diseases.12-02-2010
20090214499Feline probiotic bifidobacteria - According to the invention there is provided a strain of lactic acid bacteria of the genus 08-27-2009
20110129452PROBIOTICS TO INCREASE IgA SECRETION IN INFANTS BORN BY CAESAREAN SECTION - Use of probiotic bacteria in the manufacture of a medicament or therapeutic nutritional composition for increasing IgA secretion in an infant delivered by cesarean section during the first four months of the life of the infant.06-02-2011
20110150852Novel Strain of Lactobacillus Paracasei Subspecies Paracasei Having Antimicrobial and Immunomodulatory Properties - The invention relates to a novel strain of 06-23-2011
20110135615TRANSIENTLY BUFFERED LACTOBACILLUS PREPARATIONS AND USE THEREOF - The present invention relates to methods and compositions for 06-09-2011
20100055083ENCAPSULATION OF HEAT AND MOISTURE SENSITIVE SUBSTANCES - The present invention relates to a method for preparing a suspension for the encapsulation of heat and moisture sensitive substances in capsules, sachets, droplets and food compositions. It also relates to methods for encapsulating, to the encapsulated products and to methods for storing the encapsulated products. The invention is extremely suitable for the encapsulation of microbial cultures. Cultures encapsulated in capsules prepared according to the method of the invention, will stay stable for a long time. At 25 degrees C. they show a stability reduction of less than 1 log per month.03-04-2010
20110081328Use of selected lactic acid bacteria for reducing atherosclerosis - Strains of lactic acid bacteria selected for their capability of increasing the BSH-activity and consequently lowering serum LDL-cholesterol, and simultaneously decreasing the pro-inflammatory cytokine TNF-α levels, for prophylaxis and/or treatment of atherosclerosis and other cardiovascular diseases, a method of selecting such strains, and products containing such strains.04-07-2011
20100119497PROBIOTICS TO REDUCE EPISODES OF DIARRHOEA IN INFANTS BORN BY CAESAREAN SECTION - The use of probiotic bacteria in the manufacture of a medicament or therapeutic nutritional composition for preventing or treating diarrhoea in infants delivered by caesarean section.05-13-2010
20110250189T CELL APOPTOSIS INDUCER - An inducer of T cell apoptosis and a health food for inducing T cell apoptosis comprising as an active ingredient of a lactic acid bacterium belonging to the genus 10-13-2011
20120201797AGENT FOR REDUCING RISK OF DEVELOPING CANCER - Provided is an agent or a food or drink for reducing the risk of developing breast cancer. An agent for reducing the risk of developing breast cancer which comprises a composition containing living cells of 08-09-2012
20120201798COMPOSITIONS AND METHODS AND USES RELATED THERETO - The present invention relates to the fields of life sciences and food, feed or pharmaceutical industry. Specifically, the invention relates to a composition comprising probiotics consisting of 08-09-2012
20120201795Inhibition Of Pathogenic Growth On Plant Materials Using Lactic Acid Producing Microorganisms - Improved compositions and methods are disclosed for improving food safety. More specifically, one or more lactic acid producing microorganisms are used for inhibiting pathogenic growth on plant materials before, during and/or after harvest. The disclosed methodology is particularly effective for leafy vegetables, such as spinach.08-09-2012
20090110670Selection and use of lactic acid bacteria for reducing inflammation caused by helicobacter - Strains of 04-30-2009
20110256116Low/High Dose Probiotic Supplements And Methods Of Their Use - Methods and compositions are hereby disclosed for reducing the numbers of 10-20-2011
20080267932Lactobacillus Rhamnosus with Body-Fat Reducing Activity and the Foods Containing Them - The present invention relates to 10-30-2008
20080219961Method for Stabilising Pharmaceutical Administration Forms Comprising Microorganisms - The invention relates to a method for stabilising solid pharmaceutical administration forms which comprises at least one species of microorganism, and to a pack comprising packaging and a solid pharmaceutical administration form which comprises at least one species of microorganism.09-11-2008
20080254012Nutritional Formulation For Promoting Catch-Up Growth - This invention relates to a nutritional formulation comprising an n3 long-chain polyunsaturated fatty acid (LC-PUFA), a prebiotic fibre and a probiotic bacterial strain which ingredients act together in a synergistic fashion to promote catch-up growth in young mammals whose growth has been retarded because the young mammal has been subjected to physical or mental stress.10-16-2008
20120201796PROBIOTIC PREPARATION FOR THE PREVENTION OR TREATMENT OF CANINE GASTROINTESTINAL DISORDERS - The present invention relates to a probiotic preparation for preventing and treating canine gastrointestinal disorders containing at least two dog-specific strains of lactic acid bacteria belonging to genus 08-09-2012
20110165135LACTOBACILLUS HELVETICUS STRAINS FOR PRODUCING HYPOTENSIVE PEPTIDES - The present invention relates to novel strains of 07-07-2011
20110165134LACTOBACILLUS SP. JNU2116 WITH ANTIMUTAGENIC ACTIVITY - sp. strain with antimutagenic activity and, more particularly, 07-07-2011
20100284980Nutritional Composition To Promote Healthy Development And Growth - A nutritional formula which includes a lipid or fat; a protein source; about 5 to about 100 mg/100 kcal of a source of long chain polyunsaturated fatty acids which comprises docosahexanoic acid; about 0.1 to about 1 mg/100 kcal of a prebiotic composition, wherein the prebiotic composition comprises at least 20% of an oligosaccharide which comprises galacto-oligosaccharide; and about 0.015 to about 0.1 (pg/μg) ppm of TGF-β.11-11-2010
20100330054PREPARATION, USE OF PREPARATION FOR TREATMENT, AND METHOD OF TREATMENT OF INTESTINAL INFECTION - A preparation for use in the treatment of 12-30-2010
20110052553STRAIN OF LACTOBACILLUS PLANTARUM LP28 AND ITS USE IN TREATING HYPERSENSITIVITY REACTIONS - A new strain of 03-03-2011
20090004164Nutritional Composition With Probiotics - A composition comprising 01-01-2009
20100196340LACTID ACID BACTERIA AS PRIOBIOTIC STRAINS AND COMPOSITIONS CONTAINING SAME - Useful probiotics have been selected among lactic acid bacteria strains of the genus 08-05-2010
20100080782Use of probiotic lactic acid bacteria for balancing the skin's immune system - The present invention pertains to the use of probiotics for the preparation of a carrier for balancing the skin's immune function. In particular, the present invention pertains to the use of probiotic micro-organisms for balancing the skin's immune function under stress conditions, such as a exposure to ultraviolet radiation, specifically for enhancing the skin's immune activity and reducing the tendency to develop allergic reactions under such conditions.04-01-2010
20110189149New Uses of Lactic Acid Bacteria and Bifidobacteria - The invention comprises use of a bacterium selected from a lactic acid bacterium, a 08-04-2011
20110189148LACTOSE COMPOSITIONS WITH DECREASED LACTOSE CONTENT - The invention provides methods and compositions for treating symptoms associated with lactose intolerance and for overall improvement in gastrointestinal health. Described herein are methods and compositions for improving overall gastrointestinal health or for decreasing symptoms of lactose intolerance by administering to an individual a lactose composition with decreased lactose content in combination with effective amounts of prebiotics and/or probiotics.08-04-2011
20110189145Inhibition of Pathogens by Probiotic Bacteria - Compositions containing a lactic acid-producing bacterial strain, e.g., 08-04-2011
20110189146Methods of Use of Probiotic Lactobacilli for Companion Animals - According to the present invention there are provided methods of use in companion animals of probiotic bacteria of the genus 08-04-2011
20110189147PROCESS AND COMPOSITION FOR THE MANUFACTURE OF A MICROBIAL-BASED PRODUCT - Processes to produce microorganisms that can be incorporated into a microbial-based product that results in high viable cell yields and shelf-stable products are disclosed. These microbial-based products are useful for inhibiting pathogenic growth and as a food additive. A preferred microorganism is a lactic acid producing bacteria. In one embodiment, the process comprises inoculating a 08-04-2011
20100028313COMPOSITIONS AND METHODS FOR TREATMENT OF SKIN DISORDERS - The present invention concerns methods and compositions for prophylactic or therapeutic treatment of skin disorders by administering therapeutically or prophylactically effective amounts of a probiotic. The present invention is also concerned with the treatment of symptoms of skin disorders.02-04-2010
20100021445AGENT FOR REDUCING VISCERAL FAT - Provide a visceral fat reducing agent for reducing the diseases and conditions associated with the metabolic syndrome which represents a condition where various risk factors such as those for hypertension, hyperlipemia, glucose tolerance dysfunction, etc., have accumulated, or simply reducing an accumulation of visceral fat, wherein the effective ingredient of said visceral fat reducing agent includes fungus bodies of lactic bacteria, especially lactic bacteria belonging to the 01-28-2010
20120308539LACTIC ACID BACTERIA HAVING ACTION OF LOWERING BLOOD URIC ACID LEVEL - Various types of lactic acid bacteria were cultured in the presence of a purine, the amount of the purine consumed and the amount of purine degradation products produced were measured, and several lactic acid bacteria showing remarkable purine-decomposing ability were selected. Lactic acid bacteria that were assessed to have high purine-decomposing ability according to the above-mentioned selection were orally administered to rats reared on purine-containing feed, the general status and serum uric acid level of the rats were measured, and the effect of lactic acid bacteria administration on serum uric acid levels was examined. As a result, lactic acid bacteria that significantly suppress the increase of serum uric acid levels, 12-06-2012
20080267933Probiotics to Influence Fat Metabolism and Obesity - Use of probiotic bacteria for the manufacture of a food product, feed product, dietary supplement, nutritional product, natural remedy, pharmaceutical active formulation and medicinal product to be used for controlling weight gain, preventing obesity, increasing satiety, prolonging satiation, reducing food intake, reducing fat deposition, improving energy metabolism, enhancing insulin sensitivity, treating obesity and treating insulin insensitivity. The probiotic bacteria is at least one of 10-30-2008
20100055082Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof - The present invention includes extracts from 03-04-2010
20110014166Probiotics Spore-forming Lactic Acid Bacteria SL153 - The present invention relates to the novel 01-20-2011
20110305679Blood-Cholesterol-Lowering Strain of Lactobacillus Delbrueckii - The invention relates to a novel strain of 12-15-2011
20090214498ANTIMICROBIAL PEPTIDES AND BACTERIAL STRAINS THAT PRODUCE THEM - The present invention relates generally to the field of health promoting agents, in particular antimicrobial agents and provides antimicrobial peptides and bacterial strains that provide the antimicrobial peptides. In one aspect, the invention provides a biologically pure culture of 08-27-2009
20090035288EDIBLE PRODUCT CONTAINING BENEFICIAL BACTERIA - The present invention provides a method of preparing an edible product comprising non-viable bacteria providing a health benefit, the method comprising subjecting viable bacteria to at least two sub-lethal treatments to obtain the non-viable bacteria providing a health benefit, each sub-lethal treatment on its own not being sufficient to render the bacteria non-viable. The method porvides non-viable bacteria providing health benefits but which can conveniently be incorporated into a range of edible products.02-05-2009
20100129336Stabilized bacterial formulation - Selected strains of 05-27-2010
20110064706METHOD OF PREVENTING, CONTROLLING AND AMELIORATING URINARY TRACT INFECTIONS AND SUPPORTING DIGESTIVE HEALTH BY USING A SYNERGISTIC CRANBERRY DERIVATIVE, A D-MANNOSE COMPOSITION AND A PROPRIETARY PROBIOTIC BLEND - A method and composition prevents, controls and ameliorates urinary tract infections caused by 03-17-2011
20120045422USE OF LACTIC ACID BACTERIA TO TREAT OR PREVENT ECZEMA02-23-2012
20100015111Methods And Kits For The Treatment Inhibition, And Maintenance Of Gastrointestinal Disorders - The present invention comprises methods and kits that are useful treatment, inhibition and or maintenance of gastrointestinal disorders including inflammatory bowel disorder. The methods comprise: commencing treatment by orally administering a first dose of a pharmaceutical composition comprising from about 1 mg to about 8000 mg of an active agent and continuing said treatment, inhibition and or maintenance by orally administering an additional dose on a less than daily schedule of an active agent., either alone or in combination with a probiotic or optionally an antibiotic or optionally a prebiotic.01-21-2010
20110027243COMPOSITION BASED ON PROBIOTIC BACTERIA IN ASSOCIATION WITH A PREBIOTIC AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF RESPIRATORY PATHOLOGIES AND/OR INFECTIONS AND IN THE IMPROVEMENT OF INTESTINAL FUNCTIONALITY - The present invention relates to a composition based on probiotic bacteria and a substance having probiotic properties and the use thereof to prevent and/or treat respiratory pathologies and/or infections and simultaneously improve intestinal functionality, which may be compromised by the therapeutic treatments adopted to resolve said pathological conditions.02-03-2011
20120301452PROBIOTIC MICROORGANISMS AS ACTIVE AGENTS FOR ENHANCING THE RADIANCE OF THE SKIN'S COMPLEXION - The invention relates to the use of at least one probiotic microorganism as an active agent for preventing and/or treating impaired radiance of the skin's complexion.11-29-2012
20120301451NON-FERMENTED COMPOSITIONS COMPRISING A CEREAL BASED FRACTION AND A PROBIOTIC AND USES THEREOF - The present invention relates to a non-fermented composition having the ability to increase the formation of butyric acid in the colon and comprising at least one cereal based fraction and at least one isolated probiotic strain of 11-29-2012
20120009165BLOOD-ADIPONECTIN-CONCENTRATION INCREASE-ACCELERATOR AND/OR DECREASE-INHIBITOR THEREOF AND VISCERAL FAT ACCUMULATION INHIBITOR - Disclosed is an agent for accelerating the increase in and/or preventing the decrease in the blood adiponectin level, or a food, beverage or animal feed for accelerating the increase in and/or preventing the decrease in the blood adiponectin level, which comprises a culture or cell of a lactic acid bacterium belonging to the genus 01-12-2012
20120009164Increasing Probiotic Growth Rate and Activity Using Prebiotic Composition - Naturally occurring lecithins and/or oleic acid stimulate the growth and lactic acid producing activity of 01-12-2012
20080299099Strain composition of the lactobacillus genus and the application of strain composition of the lactobacillus genus - A subject of the invention is a composition containing strains 12-04-2008
20090142313VAGINAL DELIVERY SYSTEM - The present invention is related to an intravaginal delivery system for the controlled release of drospirenone and an estrogen, optionally also comprising one or more therapeutically active or a health-promoting substance capable of giving and/or enhancing protection against bacterial and fungal infections, and/or enhancing protection against sexually transmitted diseases. The delivery system consists of one or more compartments, one of each comprising a core and a membrane encasing the core, said core and membrane essentially consisting of a same or different polymer composition, wherein at least one compartment comprises drospirenone ant at least one compartment which may be the same or different from the one comprising drospirenone, comprises an estrogen or a mixture of drospirenone and an estrogen, and wherein the membrane or the surface of the membrane or at least one of the cores comprises said therapeutically active or a health-promoting substance.06-04-2009
20110091432ISOLATED PEDIOCOCCUS ACIDILACTICI 05B0111 AND METHOD OF PRODUCING EXOPOLYSACCHARIDE - Disclosed herein is an isolated 04-21-2011
20110104135Means for regulating the Cosmetic Appearance and/or Health of Human Keratinous Tissue - Regulating human keratinous tissue (e.g., skin, hair, and/or nails). More particularly, the invention relates to regulating the cosmetic appearance and/or health of human keratinous tissue by orally administering a dietary supplement comprising a probiotic to a human. In another aspect, the invention also relates to a method of marketing, an article of commerce, and a personal care kit.05-05-2011
20100092441USE OF NITRITES AND NITRATES AND COMPOSITIONS CONTAINING THESE - Inorganic anions nitrate and nitrite influence metabolic rate and glucose homeostasis. Infusion of nitrite iv caused an acute drop in resting energy expenditure (oxygen consumption) and nitrate, when given perorally, caused a drop in oxygen consumption during exercise and a depression of the increase in blood glucose observed after an oral glucose tolerance test. The doses of nitrate and nitrite did not cause any detectable change in methemoglobin levels of blood. Also, nitrate and nitrite did not alter lactate levels in blood. This discovery provides useful treatments to regulate the energy expenditure and glucose homeostasis of a mammal by administration of inorganic nitrite and/or nitrate.04-15-2010
20120121564Use of selected lactic acid bacteria for reducing infantile colic - The invention herein provides certain strains of lactic acid bacteria selected for their capability of promoting production of IL-10 and consequently proliferation of CD4+CD25+ TR cells, for prophylaxis and/or treatment of infant colic, a method of selecting such strains, and products containing such strains.05-17-2012
20120121563SPECIALIZED NUTRITIONAL FORMULA FOR ADULT PATIENTS WITH GASTROINTESTINAL INTOLERANCE CONTAINING PROBIOTICS - The present invention relates to the field of nutrition for adults. In particular, the present invention relates to the nutritional compositions intended for adults with an impaired function of the gastro-intestinal tract. One embodiment of the present invention relates to a nutritional composition to be administered to adults with an impaired function of the gastrointestinal tract comprising probiotic micro-organisms. The probiotic micro-organisms may be non-replicating, for example bioactive heat treated probiotic micro-organisms.05-17-2012
20120164119BACTERIOCIN-PRODUCING LACTOBACILLUS PENTOSUS AND THE USE THEREOF IN FOOD AND PHARMACEUTICAL COMPOSITIONS - The present invention relates to a selected strain of 06-28-2012
20100247500AGENT AND METHOD FOR IMPROVING SURVIVABILITY OF LACTIC ACID BACTERIUM, AND FOOD COMPOSITION - The survival of lactic acid bacterial strains such as probiotic bacteria contained in yogurt etc. is improved. A lactic acid bacterium survival improver including a propionic acid bacterium fermentation product to improve the survival of a lactic acid bacterium. The propionic acid bacterium is a bacterium belonging to the genus 09-30-2010
20110182869TREATMENT OF GUT MOTILITY DISORDERS - This invention relates to products comprising antibiotics or probiotics and the use thereof for the treatment of gut motility disorders such as irritable bowel syndrome (IBS).07-28-2011
20120213753LACTOBACILLUS PLANTARUM STRAINS AS HYPOCHOLESTEROLEMIC AGENTS - The invention relates to a composition comprising an effective amount of at least one of the strains selected from the group consisting of 08-23-2012
20120171176USE OF NUTRITIONAL COMPOSITIONS INCLUDING LACTOFERRIN AND ONE OR MORE PREBIOTICS IN INHIBITING ADHESION OF PATHOGENS IN THE GASTROINTESTINAL TRACT - A method for inhibiting the adhesion of at least one pathogen in the gastrointestinal tract of a human is disclosed herein. In certain embodiments, the method involves administering to the human a nutritional composition including a fat or lipid source, a protein source, a prebiotic composition that includes galactooligosaccharide and/or polydextrose and lactoferrin produced by a non-human source.07-05-2012
20120171178NUTRITIONAL COMPOSITION FOR SUPPORTING BRAIN DEVELOPMENT AND FUNCTION OF CHILDREN - The present invention relates to a nutritional composition, in particular directed to children of 3-6 years, said nutritional composition comprising a protein source, a source of available carbohydrates, a lipid source, at least one probiotic microorganism, and prebiotics, wherein said lipid source comprises DHA (docosahexaenoic acid) and/or ARA (arachidonic acid). The nutritional composition improves cognitive performance, in particular memory, learning comprehension, alertness, attention, concentration, processing speed, conceptual thinking, abstract thinking, verbal abilities, language comprehension, psychomotor skills, curiosity, and confident interaction with the environment. Preferably, the composition comprises one, a combination of several or all selected of the group of DHA, ARA, LA, ALA, choline, iron, iodine and folic acid.07-05-2012
20120171177NUTRITIONAL COMPOSITION FOR SUPPORTING BRAIN DEVELOPMENT AND FUNCTION OF TODDLERS - The present invention relates to a nutritional composition, in particular directed to toddlers and/or a weaning child, said nutritional composition comprising a protein source, a source of available carbohydrates, a lipid source, at least one probiotic microorganism, and prebiotics, wherein said lipid source comprises DHA (docosahexaenoic acid). The nutritional composition improves cognitive performance, in particular learning and memory of the child. Preferably, the composition comprises iron, zinc, vitamin D and/or sialic acid. Preferably, the composition comprises a source of phospholipids rich in DHA.07-05-2012
20120251511COMPOSITION AND PRODUCTS FOR ENABLING THE PRODUCTION OF EQUOL IN VIVO - The isoflavone equol has the ability to mimic estrogen at the receptor level, as well as the ability to mitigate the deleterious effects of dihydrotestosterone (DHT) in vivo, thus resulting in potential health benefits for both men and women. Only an approximated one-third of the global population has the inherent ability to produce equol. Diet and colonic bacterial composition play a large role in natural equol production. The present invention can increase the probability of producing significant quantities of equol in vivo. Experimentation has shown the repeatable and measurable evidence of equol. Data from male test subjects indicates clinically significant positive effects on androgenic alopecia and acne vulgaris.10-04-2012
20120082651BACTERIA THYA(-) MUTANTS WITH INCREASED VITAMIN K - Bacteria thyA(−) mutants with increased vitamin K and use of these thyA(−) mutants for making a composition/product for treatment and/or prevention of vitamin K deficiency in a mammal (e.g. a human).04-05-2012
20120263696Indirect Substrates for Microorganisms Metabolizing 1,2-Propanediol - The present invention relates generally to enhanced activity of certain probiotics. The increased efficacy is achieved by using certain substrate components that indirectly supply the probiotics with a specific source of energy. The substrate components are specifically designed to stimulate 1,2-propanediol production.10-18-2012
20120263695COMPOSITION HAVING STRAINS OF LACTOBACILLUS FERMENTUM - The invention relates to a pharmaceutical and/or dietetic composition for increasing the impact of the immune defense of higher living beings, wherein bacteria of the species 10-18-2012
20080299098Broad-Spectrum Antibacterial and Antifungal Activity of Lactobacillus Johnsonii D115 - The present invention demonstrated the potential use of 12-04-2008
20110002901BACTERIAL STRAIN HAVING ANTI-ALLERGIC ACTIVITY, AND BEVERAGE, FOOD AND ANTI-ALLERGIC AGENT COMPRISING CELL OF THE BACTERIAL STRAIN - It is an object of the present invention to provide a bacterial strain belonging to 01-06-2011
20120263694Intimate Lubrication Kit - The kit comprises applicators of lubricating composition for use during the days up to and including ovulation and applicators of a slightly thicker composition for use just after ovulation.10-18-2012
20120328586METHODS AND MEANS FOR PROTECTING THE SKIN AGAINST PATHOGENIC MICROORGANISMS - Described are microorganisms which are, in a first aspect, able to stimulate the growth of microorganisms of the resident skin microbial flora and which do not stimulate the growth of microorganisms of the transient pathogenic micro flora. In a second aspect microorganisms are described which are able to inhibit the growth of microorganisms of the transient pathogenic skin micro flora and which do not inhibit the growth of microorganisms of the resident skin micro flora. Also described are compositions comprising such microorganisms as well as the use of such microorganisms in cosmetic, prophylactic or therapeutic applications.12-27-2012
20120328585Nutritional Composition Having Prebiotic - The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.12-27-2012
20120269791Treatment Of IBD And IBS Using Both Probiotic Bacteria And Fermented Cereal As Treatment Effectors - The invention covers a novel treatment strategy that considerably improves conventional probiotic treatments of inflammatory bowel diseases, irritable bowel syndrome and other gastrointestinal disorders. Both probiotic microorganisms and the carrier of the probiotic microorganisms in form of a fermented cereal gruel are used as treatment effectors. Phospholipids may also be an effecter. The novel treatment strategy is capable of removing the symptoms of inflammatory bowel diseases regardless of a mild, moderate or severe stage of the disease.10-25-2012
20120269789GROWING UP MILKS CONTAINING PROBIOTIC MICRO-ORGANISMS - The present invention relates to the field of nutrition for infants and young children. In particular, the present invention relates to growing-up milks comprising probiotic micro-organisms to be administered to infants and young children older than 10 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example.10-25-2012
20120269790USE OF PLANT EXTRACTS AS PREBIOTICS, COMPOSITIONS AND FOODS CONTAINING SUCH EXTRACT - The present invention claims the use of pomegranate (Punica granaturn) plant extracts and various combinations of said extracts, some additionally including a probiotic, which allow a synergistic effect between the bioactive components thereof, for the purpose of preparing dietary supplements, functional foods/beverages, food additives and drugs for use in caring for human health.10-25-2012
20120128645PROPHYLACTIC, AMELIORATING OR THERAPEUTIC AGENT FOR ORAL DISEASES - To provide a novel lactic acid bacterium strain having a broad antibacterial spectrum against bacteria that cause oral diseases, from which a fermented product having good flavor and being excellent in palatability can be produced, and a prophylactic, ameliorating or therapeutic agent for oral diseases using the same.05-24-2012
20110236360LACTIC ACID BACTERIUM HAVING HIGH OXALIC ACID DECOMPOSITION ABILITY - The present invention provides lactic acid bacteria having oxalic acid-degrading activity several times higher than those of conventionally known lactic acid bacteria having an oxalic acid-degrading activity, and uses thereof. Lactic acid bacteria capable of degrading a large amount of oxalic acid were screened from 132 strains of 09-29-2011
20120321600INFANT FORMULA WITH PROBIOTICS AND MILK FAT GLOBULE MEMBRANE COMPONENTS - A nutritional composition is proposed comprising a probiotic and milk fat globule membrane (MFGM) wherein the MFGM and the probiotics mutually potentiate their respective effects and promote complementary beneficial protective mechanisms that reflect physiological synergy. The nutritional composition can be an infant formula, infant cereals, baby food or health care nutritional product. The synergistic effect can include promoting immune maturation and/or immune education and/or reducing inflammation and/or treating or preventing disease or infections.12-20-2012
20120087902Therapeutic Use Of Probiotics - The involvement of intestinal microbiota in the initiation and perpetuation of inflammatory bowel disease is widely accepted. To reestablish the homeostasis of the gut the use of probiotics has been proposed, with however, limited clinical benefit. This invention relates to an assay based on the modulation of the immunological activity in DCs (dendritic cells) by probiotic strains, in particular 04-12-2012
20100215627ATOPY CURE BABY DRY MILK WITH GREEN TEA AND LACTOBACILLUS - Provided is a prevention and treatment of baby atopy using green tea and 08-26-2010
20100203025LACTIC ACID BACTERIA ISOLATED FROM MOTHER'S MILK WITH PROBIOTIC ACTIVITY AND INHIBITORY ACTIVITY AGAINST BODY WEIGHT AUGMENTATION - The present invention relates to a lactic acid bacterium isolated from human mother's milk, more precisely a 08-12-2010
20100183574LACTIC ACID BACTERIA AND THEIR USE IN SWINE DIRECT-FED MICROBIALS - TRFs useful for identifying strains of interest are provided. A method of identifying one or more strain that can be used as a direct-fed microbial is also provided. One or more strain identified by the method is additionally provided. A method is also provided for administering to an animal an effective amount of the one or more strain. Additionally provided is an isolated strain chosen from at least one of 07-22-2010
20130011374GROWTH INHIBITION OF MICROORGANISMS BY LACTIC ACID BACTERIA - The present invention relates to growth inhibition of microorganisms by lactic acid bacteria. The present invention also relates to the reduction and/or treatment of food-borne pathogen infections and/or nosocomial infections. The present invention also relates to the inhibition of spoilage microorganisms in food products. The present invention further relates to the modulation of gut flora. The invention is also directed to the inhibitory potential of a whey obtained from lactic acid bacteria.01-10-2013
20130022586PRODUCTION AND USE OF BACTERIAL HISTAMINE - A method is provided of selecting specific probiotic lactic acid bacteria producing histamine and the use of such strains for beneficial effects for mammals. The method includes selecting a lactic acid bacterial strain for use in the local production of histamine in a mammal, and further comprises screening bacteria for the presence of an active histidine operon and selecting a strain which has an active histidine operon and is capable of producing histamine. Preferably said strain is selected for its ability to produce histamine at a level of greater than 250 pg/ml. The present invention further provides products comprising the strains obtainable by the selection methods of the invention for use in the local production of histamine in a mammal, in particular for use in the treatment or prophylaxis of inflammatory conditions.01-24-2013
20130171117Lactobacilli with Anti-Oxidant Action - The present invention relates to specific 07-04-2013
20130171118INTESTINAL PROTECTANT - The present invention provides an intestinal tract protective agent comprising a polyphosphoric acid or a pharmaceutically acceptable salt thereof as an active ingredient.07-04-2013
20080254011Use of selected lactic acid bacteria for reducing atherosclerosis - Strains of lactic acid bacteria selected for their capability of increasing the BSH-activity and consequently lowering serum LDL-cholesterol, and simultaneously decreasing the pro-inflammatory cytokine TNF-α levels, for prophylaxis and/or treatment of atherosclerosis and other cardiovascular diseases, a method of selecting such strains, and products containing such strains.10-16-2008
20080233092METHODS AND COMPOSITIONS FOR TREATING LACTOSE INTOLERANCE - The invention provides methods and compositions for treating lactose intolerance. In embodiments, the invention provides methods and composition for decreasing symptoms of lactose intolerance by administering to an individual suffering from lactose intolerance increasing doses of lactose using a protocol such that at the end of treatment the individual's symptoms of lactose intolerance are decreased and such that symptoms remain decreased after a period of time.09-25-2008
20110274672SIALIC ACID PRODUCING BACTERIA - The present invention generally relates to the field of sialic acids, in particular to the field of sialic acid enriched food products and their uses. One embodiment of the present invention relates to a food product enriched with food-grade sialic acid producing bacteria and/or a fraction thereof containing sialic acid.11-10-2011
20130142765LACTOCOCCUS LACTIS STRAIN WITH HIGH VITAMIN K2 PRODUCTION - The present invention relates to a novel wild-type 06-06-2013
20130177540FERULATE ESTERASE-PRODUCING BACTERIAL STRAINS AND METHODS OF USING SAME - Ferulate esterase producing bacterial strains or functional mutants thereof and methods of using ferulate esterase producing bacterial strains as forage additives are disclosed.07-11-2013
20110268715ANTI-INFLAMMATORY AND ANTI-VAGINITIS FOOD COMPOSITION AND PHARMACEUTICAL COMPOSITION CONTAINING LACTOBACILLUS - An anti-inflammatory and anti-vaginitis food composition and/or pharmaceutical composition includes 11-03-2011
20080199446Uronic Acid and Probiotics - The present invention relates to compositions containing probiotic bacteria and uronic acid oligosaccharides. The compositions can suitably be used as infant nutrition and advantageously reduce the incidence of infection.08-21-2008
20080260708METHODS AND RELATED SYSTEMS AND FORMULATIONS TO NORMALIZE AND IMPROVE HUMAN BODY CHEMISTRY AND HEALING ABILITY - Methods, systems and formulations for normalizing and improving human body chemistry and the body's natural ability to heal itself. In one embodiment a system including effective amounts of a digestive enzyme, soluble and insoluble fiber, laxative, probiotics, vitamin C, potassium, protease enzymes, lipase, lysine, taurine, proline, choline, inositol, inositol hexaphosphate, policosanol, charcoal, bentonite clay, thyme, ascorbic acid, magnesium citrate, calcium citrate, methylsulfonyl methane, cayenne pepper, magnesium, potassium, ester-c, ginger and niacin, lysine calcium, stevia leaf, citric acid, a tincture of bayberry bark, juniper berries, yam root, cramp bark, golden seal root, fennel seed, uva ursi leaves, ginger root, lobelia herb, catnip herb, and peppermint leaf, golden seal root, Echinacea angustifolia root, ginger root, and licorice root, a tincture of black walnut hulls, venus fly trap, chaparral, wormwood, licorice root, slippery elm, cloves and comfrey root, burdock root, sheep sorrel, rhubarb root, slippery elm, olive leaf and yarrow flower is provided.10-23-2008
20110236359Antimicrobial Activity of Bacteriocin-Producing Lactic Acid Bacteria - The present invention relates to novel bacteriocin-producing lactic acid bacteria strains 09-29-2011
20130149291PRODUCTION AND USE OF BACTERIAL HISTAMINE - A method is provided of selecting specific probiotic lactic acid bacteria producing histamine and the use of such strains for beneficial effects for mammals. The method includes selecting a lactic acid bacterial strain for use in the local production of histamine in a mammal, and further comprises screening bacteria for the presence of an. active histidine operon and selecting a strain which has an active histidine operon and is capable of producing histamine. Preferably said strain is selected for its ability to produce histamine at a level of greater than 250 pg/ml. The present invention further provides products comprising the strains obtainable by the selection methods of the invention for use in the local production, of histamine in a mammal, in particular for use in the treatment or prophylaxis of inflammatory conditions.06-13-2013
20100316619NUTRITIONAL COMPOSITION WITH PREBIOTIC COMPONENT - The present disclosure relates to nutritional compositions comprising a prebiotic component for inhibiting adherence of pathogens in the gastrointestinal tract of a subject and to the prebiotic component, which comprises galactooligosaccharide, polydextrose or any mixture thereof. The nutritional compositions of the present disclosure comprise a fat or lipid source, a protein source, and a carbohydrate source comprising an effective amount of the prebiotic component.12-16-2010
20100316618LACTIC ACID BACTERIUM HAVING EFFECT OF LOWERING BLOOD URIC ACID LEVEL - The present invention provides lactic acid bacteria which are suitable for use for dietary products and pharmaceuticals, and which can suppress the increase of blood uric acid level.12-16-2010
20120282232Nutrient Hydration Bar - The method of the present invention comprises the administration of a complete matrix of natural whole food vitamins, minerals including necessary electrolytes, super anti-oxidants, proteins, amino acids, complex carbohydrates, fiber, lipids and bio-flavonoids with superior absorption, utilization and retention. The supplement provides a consumer or athlete enhanced hydration retention and energy which is extremely effective in enhancing exercise and sports performance.11-08-2012
20110311502AGENT FOR PREVENTION OR AMELIORATION OF OBESITY - To provide a pharmaceutical product or food which has an excellent fat-accumulation-inhibiting activity and/or fat-metabolism-improving activity and which is effective for inhibition or improvement of obesity, fatty liver, etc.12-22-2011
20110311501ANTI-OBESITY AGENT AND ANTI-OBESITY FOOD - An anti-obesity agent containing, as an active ingredient, a microorganism which belongs to the species 12-22-2011
20130189236Prevention And Treatment Of Gastrointestinal Infection In Mammals - Methods are disclosed for the prevention and/or treatment of certain gastrointestinal (GI) diseases, such as Johne's Diseases (JD) in animals and Crohn's Disease (CD) in human. Administration of certain probiotic bacteria, such as lactic acid producing bacteria, to animals helps inhibit GI infection by 07-25-2013
20120020944USE OF A PROBIOTIC TO REGULATE BODY WEIGHT - The use of probiotic bacteria that modulate expression of a number of satiety markers in the intestine and reduces fat deposition to promote an optimal body weight of a mammal is described. The invention further relates to a composition comprising such a probiotic strain of bacteria and/or a fraction of said strain and/or metabolite of said strain for the preparation of a composition for administration to a mammal for promoting an optimal body weight of a mammal.01-26-2012
20120020943Lactobacillus Plantarum and Uses Thereof - Provided is an isolated 01-26-2012
20120020942Novel Lactobacillus Strains And Their Use Against Helicobacter Pylori - The invention concerns new isolated 01-26-2012
20120027738MATERNAL SUPPLEMENT - The use of docosahexaenoic acid in the manufacture of a composition for administration to a pregnant woman for reducing the risk of development of overweight or obesity of the baby in infancy and/or early childhood.02-02-2012
20120027737USE OF PROBIOTICS TO AMELIORATE DIET-INDUCED INSULIN RESISTANCE - The invention relates to the use of a composition comprising probiotic bacteria that regulate expression of key components involved in diet-induced insulin resistance for ameliorating or preventing diet-induced insulin resistance. The use of the probiotic strain and/or a fraction of said strain and/or metabolite of said strain for the manufacture of a medicament or a food or feed product to ameliorate diet-induced insulin resistance and help to obtain optimal body weight of a mammal is disclosed. Preferably, the composition comprises at least one probiotic 02-02-2012
20120027736ANTI-OBESITY AGENT AND ANTI-OBESITY FOOD - An anti-obesity agent containing, as an active ingredient, a microorganism which belongs to the species 02-02-2012
20130195823USE OF LACTOBSCILLI INHIBITING GAS PRODUCTS COLIFORM BACTERIA ISOLATED FROM INFANTS AFFECTED BY COLIC - The present invention relates to a composition comprising two probiotic strains of bacteria capable of performing an antioxidant and/or antibacterial and competitive action against species of coliform bacteria that produce gas by fermentation of sugar, in particular lactose, isolated from infants affected by colic.08-01-2013
20130195822Probiotic Strains for Use in Improving the Enteric Nervous System - The invention relates to the use of lactic acid bacteria, for use in modifying the enteric nervous system and more particularly in treating and/or preventing intestinal disorders such as constipation and/or irritable bowel disease.08-01-2013
20130202570Treatment of Neurocutaneous Syndrome, Including Compositions, Methods and Uses Thereof - A treatment protocol for use in the treatment of neurocutaneous syndrome is described and comprises at least one xanthone component, which may comprise at least one mangosteen component, and at least one detoxification component. Additional embodiments comprise at least one herbal component, at least one vitamin component, or a combination thereof. A method of treating a patient having neurocutaneous syndrome is described herein and comprises: providing at least one xanthone component, which may comprise at least one mangosteen component, providing at least one xanthone component, which may comprise at least one mangosteen component, to the patient, and administering the at least one detoxification component to the patient. Additional methods steps may include providing and administering at least one herbal component, providing and administering at least one vitamin component or a combination thereof.08-08-2013
20130202571USE OF PROBIOTIC BACTERIA TO PREVENT AND TREAT LISTERIAL INFECTIONS - This invention relates to LAP-expressing probiotic bacteria and methods of use thereof to prevent and treat a pathogenic bacterial infection.08-08-2013

Patent applications in class Lactobacillus or Pediococcus or Leuconostoc